Proportion of participants with anomalous head position preoperatively with residual head tilt postoperatively · people with symptom‐producing and/or socially noticeable unilateral overacting inferior oblique muscle; all participants had longstanding…
1 finding from 1 review
Proportion of participants with postoperative hypertropia less than 3 PD in down gaze · people with symptom‐producing and/or socially noticeable unilateral overacting inferior oblique muscle; all participants had longstanding…
1 finding from 1 review
Proportion of participants with postoperative hypertropia less than 3 PD in contralateral gaze · people with symptom‐producing and/or socially noticeable unilateral overacting inferior oblique muscle; all participants had longstanding…
1 finding from 1 review
Proportion of participants who received additional strabismus surgery · people with symptom‐producing and/or socially noticeable unilateral overacting inferior oblique muscle; all participants had longstanding…
1 finding from 1 review
Proportion of participants with reversal of vertical deviation postoperatively · people with symptom‐producing and/or socially noticeable unilateral overacting inferior oblique muscle; all participants had longstanding…
1 finding from 1 review
Proportion of participants with postoperative orbital cellulitis · people with symptom‐producing and/or socially noticeable unilateral overacting inferior oblique muscle; all participants had longstanding…
1 finding from 1 review
Proportion of participants with anomalous head position preoperatively with residual head tilt postoperatively · people with unilateral superior oblique palsy
It is very uncertain whether inferior oblique disinsertion changes proportion of participants with anomalous head position… compared with anterior transposition (very low certainty).
1 finding from 1 review
Surgical site infection · S aureus carriers undergoing cardiac surgery
Mupirocin showed no clear difference in SSI compared with placebo (low certainty).
1 finding from 1 review
S aureus SSI · S aureus carriers undergoing cardiac surgery
Mupirocin showed no clear difference in S aureus SSI compared with placebo (low certainty).
1 finding from 1 review
All‐cause mortality · S aureus carriers undergoing cardiac surgery
Mupirocin showed no clear difference in mortality compared with placebo (low certainty).
1 finding from 1 review
Adverse events · S aureus carriers undergoing cardiac surgery
1 finding from 1 review
Surgical site infection · S aureus carriers undergoing cardiac surgery
It is very uncertain whether anerdian changes SSI compared with no treatment (very low certainty).
1 finding from 1 review
Adverse events · S aureus carriers undergoing cardiac surgery
1 finding from 1 review
Intervention not reported
Oswestry Disability Index ‐ 6 months (0 to 100%) · lumbar spinal stenosis
The intervention showed no clear difference in oswestry Disability Index ‐ 6 months (0 to 100%) (low certainty).
1 finding from 1 review
Intervention not reported
Oswestry Disability Index ‐ 1 year (0 to 100%) · lumbar spinal stenosis
The intervention showed no clear difference in oswestry Disability Index ‐ 1 year (0 to 100%) (low certainty).
1 finding from 1 review
Intervention not reported
Oswestry Disability Index ‐ 2 years (0 to 100%) · lumbar spinal stenosis
The intervention showed no clear difference in oswestry Disability Index ‐ 2 years (0 to 100%) (low certainty).
1 finding from 1 review
Intervention not reported
Pain ‐ 3 months (0 to 10) · lumbar spinal stenosis
The intervention may leads to higher pain ‐ 3 months (0 to 10) (low certainty).
1 finding from 1 review
Intervention not reported
Pain ‐ 4 years (0 to 10) · lumbar spinal stenosis
The intervention may leads to higher pain ‐ 4 years (0 to 10) (low certainty).
1 finding from 1 review
Intervention not reported
Pain ‐ 10 years (0 to 10) · lumbar spinal stenosis
The intervention may leads to higher pain ‐ 10 years (0 to 10) (low certainty).
1 finding from 1 review
Intervention not reported
Oswestry Disability Index ‐ 6 weeks · lumbar spinal stenosis
The intervention showed no clear difference in oswestry Disability Index ‐ 6 weeks (low certainty).
1 finding from 1 review